Can sonographic imaging of the fetal pancreas predict perinatal outcomes in gestational diabetes mellitus?


Journal

Journal of perinatal medicine
ISSN: 1619-3997
Titre abrégé: J Perinat Med
Pays: Germany
ID NLM: 0361031

Informations de publication

Date de publication:
25 Nov 2022
Historique:
received: 30 01 2022
accepted: 27 04 2022
pubmed: 25 5 2022
medline: 11 11 2022
entrez: 24 5 2022
Statut: epublish

Résumé

To evaluate whether fetal pancreatic echogenicity and its measurements are associated with gestational diabetes mellitus (GDM) and perinatal outcomes. A prospective cohort study was conducted with 150 pregnant women with a singleton pregnancy. The study included pregnant women between 30 and 41 weeks with or without GDM. Fetal pancreatic circumference was measured using the free-hand tracking function. The echogenicity of the fetal pancreas was compared with the echogenicity of the liver and bone (ribs, spine) and classified as Grades 1, 2 and 3. The relationship between maternal characteristics and perinatal outcomes with fetal pancreas measurements and echogenicity was evaluated. Pregnant women with 75 GDM and 75 without GDM were included in the study. Mean fetal pancreas circumference measurements were significantly higher in pregnant women with GDM than in those without GDM (p=0.001). Hyperechogenic (Grade 3) fetal pancreas was significantly higher in pregnant women with GDM than in pregnant women without GDM, and there was a positive correlation between pancreatic echogenicity and HbA Fetal pancreatic echogenicity and measurements in pregnant women with GDM can give an idea about glucose regulation and adverse perinatal outcomes.

Identifiants

pubmed: 35607725
pii: jpm-2022-0050
doi: 10.1515/jpm-2022-0050
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1189-1197

Informations de copyright

© 2022 Walter de Gruyter GmbH, Berlin/Boston.

Références

Ogurtsova, K, da Rocha Fernandes, JD, Huang, Y, Linnenkamp, U, Guariguata, L, Cho, NH, et al.. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40–50. https://doi.org/10.1016/j.diabres.2017.03.024.
Schneider, S, Bock, C, Wetzel, M, Maul, H, Loerbroks, A. The prevalence of gestational diabetes in advanced economies. J Perinat Med 2012;40:511–20. https://doi.org/10.1515/jpm-2012-0015.
Vince, K, Perkovic, P, Matijevic, R. What is known and what remains unresolved regarding gestational diabetes mellitus (GDM). J Perinat Med 2020;48:757–63. https://doi.org/10.1515/jpm-2020-0254.
Abell, SK, De Courten, B, Boyle, JA, Teede, HJ. Inflammatory and other biomarkers: role in pathophysiology and prediction of gestational diabetes mellitus. Int J Mol Sci 2015;16:13442–73. https://doi.org/10.3390/ijms160613442.
Plows, JF, Stanley, JL, Baker, PN, Reynolds, CM, Vickers, MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci 2018;19. https://doi.org/10.3390/ijms19113342.
van Geenen, EJ, Smits, MM, Schreuder, TC, van der Peet, DL, Bloemena, E, Mulder, CJ. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 2010;39:1185–90. https://doi.org/10.1097/mpa.0b013e3181f6fce2.
Jeong, HT, Lee, MS, Kim, MJ. Quantitative analysis of pancreatic echogenicity on transabdominal sonography: correlations with metabolic syndrome. J Clin Ultrasound 2015;43:98–108. https://doi.org/10.1002/jcu.22200.
Smereczynski, A, Kolaczyk, K. Is a fatty pancreas a banal lesion? J Ultrason 2016;16:273–80.
Pedersen, J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol 1954;16:330–42. https://doi.org/10.1530/acta.0.0160330.
Akkaya, H, Buke, B, Uysal, G. Fetal pancreatic hyperechogenicity may be an early ultrasonographic sign of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2020;33:2387–94.https://doi.org/10.1080/14767058.2018.1551351.
Gilboa, Y, Krekora, M, Perlman, S, Bardin, R, Kassif, E, Achiron, R, et al.. Sonographic measurement of the fetal pancreas in women with gestational diabetes. Arch Med Sci 2022;18. https://doi.org/10.5114/aoms/140578.
International Association of D, Pregnancy Study Groups Consensus P, Metzger, BE, Gabbe, SG, Persson, B, Buchanan, TA, et al.. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82. https://doi.org/10.2337/dc09-1848.
Fowden, AL, Hughes, P, Comline, RS. The effects of insulin on the growth rate of the sheep fetus during late gestation. Q J Exp Physiol 1989;74:703–14. https://doi.org/10.1113/expphysiol.1989.sp003322.
Green, AS, Rozance, PJ, Limesand, SW. Consequences of a compromised intrauterine environment on islet function. J Endocrinol 2010;205:211–24. https://doi.org/10.1677/joe-09-0399.
Beringue, F, Blondeau, B, Castellotti, MC, Breant, B, Czernichow, P, Polak, M. Endocrine pancreas development in growth-retarded human fetuses. Diabetes 2002;51:385–91. https://doi.org/10.2337/diabetes.51.2.385.
Mathai, S, Cutfield, WS, Derraik, JG, Dalziel, SR, Harding, JE, Robinson, E, et al.. Insulin sensitivity and beta-cell function in adults born preterm and their children. Diabetes 2012;61:2479–83. https://doi.org/10.2337/db11-1672.
Milovanovic, I, Njuieyon, F, Deghmoun, S, Chevenne, D, Levy-Marchal, C, Beltrand, J. SGA children with moderate catch-up growth are showing the impaired insulin secretion at the age of 4. PLoS One 2014;9:e100337. https://doi.org/10.1371/journal.pone.0100337.
White, V, Jawerbaum, A, Mazzucco, MB, Gauster, M, Desoye, G, Hiden, U. Diabetes-associated changes in the fetal insulin/insulin-like growth factor system are organ specific in rats. Pediatr Res 2015;77:48–55. https://doi.org/10.1038/pr.2014.139.
Group, HSCR. Hyperglycemia and adverse pregnancy outcome (HAPO) study: associations with neonatal anthropometrics. Diabetes 2009;58:453–9. https://doi.org/10.2337/db08-1112.
Ryan, EA, Liu, D, Bell, RC, Finegood, DT, Crawford, J. Long-term consequences in offspring of diabetes in pregnancy: studies with syngeneic islet-transplanted streptozotocin-diabetic rats. Endocrinology 1995;136:5587–92. https://doi.org/10.1210/endo.136.12.7588312.
Hata, K, Hata, T, Kitao, M. Ultrasonographic identification and measurement of the human fetal pancreas in utero. Int J Gynaecol Obstet 1988;26:61–4. https://doi.org/10.1016/0020-7292(88)90197-x.
Kivilevitch, Z, Achiron, R, Perlman, S, Gilboa, Y. The normal fetal pancreas. J Ultrasound Med 2017;36:1997–2005. https://doi.org/10.1002/jum.14233.
Guillam, MT, Hummler, E, Schaerer, E, Yeh, JI, Birnbaum, MJ, Beermann, F, et al.. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet 1997;17:327–30. https://doi.org/10.1038/ng1197-327.
Carl, J, Christensen, M, Mathiesen, O. Human placental lactogen (hPL) model for the normal pregnancy. Placenta 1991;12:289–98. https://doi.org/10.1016/0143-4004(91)90011-4.
Nadal, A, Alonso-Magdalena, P, Soriano, S, Ropero, AB, Quesada, I. The role of oestrogens in the adaptation of islets to insulin resistance. J Physiol 2009;587:5031–7. https://doi.org/10.1113/jphysiol.2009.177188.
Wu, WC, Wang, CY. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study. Cardiovasc Diabetol 2013;12:77. https://doi.org/10.1186/1475-2840-12-77.
Fong, A, Serra, AE, Gabby, L, Wing, DA, Berkowitz, KM. Use of hemoglobin A1c as an early predictor of gestational diabetes mellitus. Am J Obstet Gynecol 2014;211:641.e1–7. https://doi.org/10.1016/j.ajog.2014.06.016.
Barquiel, B, Herranz, L, Hillman, N, Burgos, MA, Grande, C, Tukia, KM, et al.. HbA1c and gestational weight gain are factors that influence neonatal outcome in mothers with gestational diabetes. J Womens Health (Larchmt) 2016;25:579–85. https://doi.org/10.1089/jwh.2015.5432.
Li, N, Liu, E, Guo, J, Pan, L, Li, B, Wang, P, et al.. Maternal prepregnancy body mass index and gestational weight gain on pregnancy outcomes. PLoS One 2013;8:e82310. https://doi.org/10.1371/journal.pone.0082310.
Antoniou, MC, Gilbert, L, Gross, J, Rossel, JB, Fischer Fumeaux, CJ, Vial, Y, et al.. Potentially modifiable predictors of adverse neonatal and maternal outcomes in pregnancies with gestational diabetes mellitus: can they help for future risk stratification and risk-adapted patient care? BMC Pregnancy Childbirth 2019;19:469. https://doi.org/10.1186/s12884-019-2610-2.
Barta, E, Drugan, A. Glucose transport from mother to fetus--a theoretical study. J Theor Biol 2010;263:295–302. https://doi.org/10.1016/j.jtbi.2009.12.010.
Stubbs, WA, Stubbs, SM. Hyperinsulinism, diabetes mellitus, and respiratory distress of the newborn: a common link? Lancet 1978;1:308–9. https://doi.org/10.1016/s0140-6736(78)90075-2.
Battarbee, AN, Venkatesh, KK, Aliaga, S, Boggess, KA. The association of pregestational and gestational diabetes with severe neonatal morbidity and mortality. J Perinatol 2020;40:232–9. https://doi.org/10.1038/s41372-019-0516-5.

Auteurs

Hakan Golbasi (H)

Department of Obstetrics and Gynecology Division of Perinatology, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey.

Burak Bayraktar (B)

Department of Obstetrics and Gynecology, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey.

Ceren Golbasi (C)

Department of Obstetrics and Gynecology, Izmir Tinaztepe University Faculty of Medicine, Izmir, Turkey.

Ibrahim Omeroglu (I)

Department of Obstetrics and Gynecology Division of Perinatology, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey.

Duygu Adiyaman (D)

Department of Obstetrics and Gynecology Division of Perinatology, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey.

Baris Sever (B)

Department of Obstetrics and Gynecology Division of Perinatology, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey.

Atalay Ekin (A)

Department of Obstetrics and Gynecology Division of Perinatology, University of Health Sciences Tepecik Training and Research Hospital, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH